Latest news

Thumbnail image for NICE OK for Bravtovi skin cancer drug

NICE OK for Bravtovi skin cancer drug

The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for some people with melanoma.

18th January 2019

Thumbnail image for Janssen to use Apple watch for AFib

Janssen to use Apple watch for AFib

Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, including stroke prevention, intending to to collaborate with Apple to assess the impact of the wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes.

18th January 2019

Thumbnail image for NICE approval for Verzenios in metastatic breast cancer

NICE approval for Verzenios in metastatic breast cancer

The National Institute for Health and Care Excellence has recommended Eli Lilly’s Verzenios in combination with an aromatase inhibitor as treatment option for locally advanced or metastatic breast cancer

17th January 2019

Thumbnail image for Scholl and COP announce partnership

Scholl and COP announce partnership

Footcare brand Scholl has announced it is joining forces with The College of Podiatry (COP) to raise awareness of foot health.

17th January 2019

Thumbnail image for New breast cancer testing tool in development

New breast cancer testing tool in development

A study carried out by researchers from the University of Cambridge, National Cancer Institute, National Institutes of Health in the US among others has shown how putting different genetic and risk factor data into a prediction equation could help us understand how likely a woman is to develop breast cancer.

16th January 2019

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download